USPTO 2015–2025 USPTO PatentsView US Corporation

Cpsi Holdings LLC

USPTO PatentsView assignee record - 19 granted patents across 12 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Cpsi ranks #15,205 of 49,997 tracked US assignees by granted-patent volume, with 19 patents across 12 technology areas.

#15,205
of 49,997 US assignees by volume
Top 24%
by Innovation Score (45.1/100)
18.1
avg claims per patent
-10%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R15205 · US Corporation #15,205 · 19 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

  • GRANTS-MICRO 19 grants
  • MID-PACK #15,205/49,997
  • PHOTO-FINISH Cochrane USA
  • CPC-FOCUS A61B · 12 areas
  • INNOV-PAR 45.1/100
  • CLAIMS-RICH 18.1 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-FLAT -10% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Cochrane USA Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cpsi’s 45.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Cpsi

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Cpsi's Innovation Score is 45.1/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Cpsi?

Each dot is one of Cpsi’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cpsi’s own 18.1 claims/patent is ABOVE the 13.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Cpsi vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 18.918.91919.1 0510152025 Granted patents (volume) Avg claims / patent Cochrane USA Inc. - 19, 3.32Cochrane USAColt's Manufacturing IP Holding Company LLC - 19, 15.58Colt's Manufactur…Commercial Sewing, Inc. - 19, 11.47Commercial SewingCompass Plants B.V. - 19, 1Compass Plants B VCrown Iron Works Company LLC - 19, 13.11Crown Iron WorksCSA Medical, Inc. - 19, 19.32CSA MedicalCSIdentity Corporation - 19, 19.26CsidentityCuronix LLC - 19, 19.58CuronixCpsi Holdings LLC - 19, 18.05Cpsi Holdings
Cpsi vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cpsi's grants concentrate

Cpsi Holdings LLC is a focused PatentsView assignee: 12 CPC subclasses with 68.4% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2018 (5 grants) versus a trough of 1 in 2015. By volume, Cpsi sits between Cochrane USA Inc. and Curonix LLC.

Cpsi's three-year grant acceleration

Cpsi Holdings LLC shows 7 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Cpsi's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Cpsi holds 19 patents at rank #15,187, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Cpsi

By rank, the assignees closest to #15,187 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Cpsi's primary technology class.

Cpsi's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 24% higher than 76% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 2015201720182019202120222024 5
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Cpsi Holdings LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 5.3%
2017 2 10.5%
2018 5 26.3%
2019 2 10.5%
2021 2 10.5%
2022 2 10.5%
2024 5 26.3%

Which technologies does Cpsi Holdings LLC patent most?

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Cpsi Holdings LLC's patent record in context - here's where to go next.

  • Cpsi Holdings LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 68.4% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #15,205 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Cpsi Holdings LLC against Cochrane USA Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 45.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.